Anondita Medicare Limited ANONDITAshare price and chart
Anondita Medicare closed at ₹1,038.45 on 19 November 2026, down 1.97% on the day. The 52-week range is ₹599.06 to ₹1,309.58.
Daily candlesEach candle is one trading day. The chart opens on the last year; drag back past the start or open full screen and the rest loads, back to listing (or the first day in our data). The body runs from the open to the close, the thin lines to the high and low. Green closed up, red closed down.
Loading prices…
Split and bonus adjusted daily candles. Drag back past the start, or open full screen, and its whole history loads. Scroll or pinch to zoom; full screen adds indicators, drawing and measuring.Test a strategy on ANONDITA
Real prices, every charge counted. Pick one or write your own.Anondita Medicare makes male condoms under the COBRA brand, including flavoured variants, at its plant in Noida, Uttar Pradesh. It raised its capacity by 307 million pieces in February 2026 to 869 million a year.
Personal Products
Condoms (COBRA brand)
Technical snapshotHow the share has been behaving: its momentum, its trend, how much of the trading was real buying to keep, and its returns.
EOD 19 NovThe share of traded quantity that was actually delivered (not squared off intraday) - high delivery vs its 20-session average suggests real buying or holding, not just churn.
Returns and valuationWhat the market pays for this company and how well the business uses its money.
Books to 30 Sept 2026Against its sectorWhere this company ranks among similar companies on each measure.
Personal Care · 13 peers · mediansWhat it has returnedThe yearly growth rate in the share price over each period, as if it had grown smoothly.
Price only, before dividendsShareholding patternThe share of the company held by its promoters, by foreign and domestic institutions, and by the public, quarter by quarter.
Who owns itEach line is that holder's share of all shares over the last 4 quarters, drawn to its own scale - the printed change is the size of the move. Mutual funds and insurers sit inside the domestic figure; hover the bar above for that split.
The promoter/promoter-group stake as a percentage of total shares, each quarter since listing. A rising line means promoters are adding to their stake; a falling one often means dilution, pledge-driven sales, or stake sales to new investors.
Insider tradesPurchases and sales of the company's own shares by promoters, directors and senior staff.
Last 18 monthsRecent announcementsThe company's own filings to the exchange in the last six months: results, board meetings, investor calls and more, each with its source document.
Last 6 monthsKey ratios at a glanceThe eight figures most people check first, each placed against companies in the same industry.
Against its sectorPeers are the listed companies in the exchange's own industry group: Personal Care. Balance-sheet figures are from the latest filed balance sheet; trends show each financial year we hold.
Cash flowProfit is an accounting figure. Cash flow shows the money that really moved: in from the business, out on investments, and to or from lenders and shareholders.
Where the cash wentIn FY26 cash rose by ₹9 Cr, after ₹63 Cr spent on plant and equipment.
The full numbersSales and net profit by financial year or by quarter.
Peers side by sideCompanies in the same exchange-defined industry group, largest first. Tap a heading to sort.
Personal Care| Company | What the whole company is worth on the stock market: share price times the number of shares. It measures size, not quality. | How many rupees investors pay today for one rupee of the company's yearly profit. A P/E of 20 means paying ₹20 for ₹1 of annual profit. | The share price against the shareholders' money per share on the balance sheet. It asks what you pay for each rupee the owners have in the business. | How much profit the company made on the shareholders' money in the business. 15% means ₹15 of profit a year on every ₹100 of owners' money. | How much operating profit the company made on all the money in the business, whether it came from owners or lenders. | Borrowings compared with the shareholders' money. 1 means the company owes as much as its owners have put in; 0 means no borrowings. | Of every ₹100 of sales, how much is left as profit after all costs, interest and tax. | How much sales grew in the latest quarter against the same quarter a year earlier. | The cash paid out in a year as a percentage of today's share price. A 2% yield means ₹2 a year on a ₹100 share. |
|---|---|---|---|---|---|---|---|---|---|
| GODREJCP Godrej Consumer Products Limited | 95,116 cr | 48.1x | 7.5x | 15.1% | 17.9% | 0.37 | 11.9% | +15.4% | 2.15% |
| DABUR Dabur India Limited | 69,300 cr | 34.2x | 6.0x | 16.2% | 20.7% | 0.10 | 14.4% | +11.7% | 2.30% |
| CUPID Cupid Limited | 49,208 cr | 290.4x | 87.4x | 27.3% | 33.9% | 0.19 | 30.5% | +122.5% | 0.00% |
| COLPAL Colgate Palmolive (India) Limited | 48,321 cr | 35.5x | 29.9x | 81.6% | 110.1% | 0.00 | 21.3% | +12.3% | 2.70% |
| GILLETTE Gillette India Limited | 23,310 cr | 34.1x | 21.7x | 69.1% | 94.3% | 0.00 | 21.3% | +4.3% | 4.19% |
| PGHH Procter & Gamble Hygiene and Health Care Limited | 22,469 cr | 28.9x | 25.4x | 113.7% | 156.1% | 0.00 | 18.3% | -0.4% | 3.68% |
| EMAMILTD Emami Limited | 18,556 cr | 24.9x | 6.3x | 27.6% | 29.7% | 0.06 | 17.8% | +36.2% | 2.59% |
| HONASA Honasa Consumer Limited | 17,268 cr | 61.0x | 11.6x | 15.4% | 20.9% | 0.00 | 10.3% | +35.9% | 0.57% |
| BAJAJCON Bajaj Consumer Care Limited | 5,321 cr | 21.5x | 5.9x | 25.3% | 31.0% | 0.00 | 19.2% | +25.5% | 0.00% |
| ANONDITA Anondita Medicare Limited | 1,978 cr | 44.1x | 8.2x | - | 31.0% | 0.29 | 41.6% | +35.9% | 0.00% |
| MACOBSTECH Macobs Technologies Limited | 186 cr | 44.5x | 5.5x | - | 13.4% | 0.22 | 7.3% | - | 0.00% |
| AAKAAR Aakaar Medical Technologies Limited | 94 cr | 8.5x | 1.6x | - | 15.0% | 0.33 | 12.8% | +72.7% | 0.00% |
| JHS JHS Svendgaard Laboratories Limited | 70 cr | - | 0.4x | -1.1% | -0.8% | 0.08 | -1.1% | -2.0% | 0.00% |
| MEDISTEP Medistep Healthcare Limited | 27 cr | - | 0.8x | - | - | 0.02 | - | - | 0.00% |
Swipe the table sideways for more columns. Tap a heading to sort. A dash means the figure is not filed or cannot be worked out for that company. A bigger cohort is cut to its 40 largest companies.
Monthly price changeThe share's price change in every calendar month, one row per year, so you can check for yourself whether a month has a pattern.
Month by month| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -6.3 | -21.3 | -12.2 | +51.7 | +6.3 | +8.2 | -5.2 | -1.2 | +1.3 | -10.1 | +6.5 | · | +2.6% 11m |
| 2025 | · | · | · | · | · | · | · | · | · | +68.0 | +8.4 | +57.5 | +186.8% 3m |
Month-on-month change in closing price, adjusted for splits and bonuses but not for dividends, so a large dividend shows up here as a fall. Starts from 1995, when the exchange began trading equities, or from the stock's listing if later. This is a record of what happened, not a forecast.
Deals and filingsLarge trades reported to the exchange, plus the company's documents sorted by type.
| Date | Party | Side | Quantity | Price | Value |
|---|---|---|---|---|---|
| 2026-03-17 | MANSI SHARE AND STOCK BROKING PRIVATE LIMITED · bulk | BUY | 1,18,000 | ₹718.00 | ₹8.47 Cr |
| 2026-03-17 | MULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITED · bulk | SELL | 1,18,000 | ₹718.00 | ₹8.47 Cr |
| 2025-09-30 | COGNIZANT CAPITAL DYNAMIC OPPORTUNITIES FUND · bulk | SELL | 1,70,000 | ₹340.04 | ₹5.78 Cr |
| 2025-09-15 | NIKUNJ KAUSHIK SHAH · bulk | SELL | 93,000 | ₹401.29 | ₹3.73 Cr |
| 2025-09-15 | NIKUNJ KAUSHIK SHAH · bulk | BUY | 93,000 | ₹399.01 | ₹3.71 Cr |
| 2025-09-04 | CINCO STOCK VISION LLP · bulk | SELL | 1,00,000 | ₹334.75 | ₹3.35 Cr |
| 2025-09-01 | S I INVESTMENTS ## BROKING PVT.LTD · bulk | BUY | 3,49,000 | ₹275.50 | ₹9.61 Cr |
| 2025-09-01 | RITU BAPNA · bulk | BUY | 2,55,000 | ₹278.98 | ₹7.11 Cr |
- Integrated Filing- Financial14 Nov 2026
Anondita Medicare Limited has informed the Exchange regarding ' Integrated Standalone and Consolidated Financial Result for half year ended September 30, 2026'.
- Board outcomeOutcome of Board Meeting14 Nov 2026
Anondita Medicare Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.
- Integrated Filing- Financial29 May 2026
Integrated filing (Financial) for the Half Year and Financial Year ended on March 31, 2026
- Integrated Filing- Financial22 May 2026
Integrated filing (Financial) for the Half Year and Financial Year ended on March 31, 2026
- Board outcomeOutcome of Board Meeting22 May 2026
Anondita Medicare Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
- Integrated Filing- Financial13 Nov 2025
ANONDITA MEDICARE LIMITED has submitted to the Exchange, the Integrated financial results for the period ended September 30, 2025
- Board outcomeOutcome of Board Meeting13 Nov 2025
Anondita Medicare Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025.
- Board outcomeOutcome of Board Meeting13 Nov 2025
Anondita Medicare Limited has informed the Exchange regarding outcome of the Board meeting held on November 13, 2025 and approved the Unaudited Standalone and Consolidated Half yearly Financial Results for the half year ended 30th September 2025 together with the Statement of Assets and...
The last two years of the company's filings to the exchange, grouped by the exchange's own categories. Each opens the original document.
Read enough? Test ANONDITA. “Buy ANONDITA when RSI(14) drops below 30, sell at 10% profit or after 20 days.” Real prices, every charge counted.
Run it free